主页
市场
图表与思路
Algo
新闻
商店
经纪商
下载
经济日历
交易信号
网页端
热图
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
B
BBP
Virtus LifeSci Biotech Products ETF
86.2
6
USD
-1.23%
版块:
金融
基础:
USD
利润货币:
USD
日范围
年范围
日变化
-1.23%
每月变动
+2.41%
6个月变化
+9.58%
年变化
+53.38%
前一天收盘价
87.3
3
Open
86.2
6
最低价
86.2
6
High
86.2
6
交易量
1
市场
US ETFs
BBP
展开完整图表
完整图表
概览
所有持仓
热图
主要持股
Market Value
Shares
Weight %
TBPH
THERAVANCE BIOPHARMA INC
712.4 K
37.6 K
1.6%
VRTX
VERTEX PHARMACEUTICALS INC
710.0 K
1 511.0
1.6%
BIIB
BIOGEN INC
705.7 K
3 923.0
1.6%
BBIO
Bridgebio Pharma Inc
702.6 K
9 093.0
1.6%
Ascendis Pharma A/S
700.9 K
3 100.0
1.6%
IONS
IONIS PHARMACEUTICALS INC
698.9 K
8 454.0
1.6%
LGND
LIGAND PHARMACEUTICALS
692.5 K
3 605.0
1.5%
EXEL
EXELIXIS INC
691.4 K
16.7 K
1.5%
GERN
Geron Corp
688.4 K
502.5 K
1.5%
AGIO
AGIOS PHARMACEUTICALS INC
687.6 K
25.1 K
1.5%
REGN
REGENERON PHARMACEUTICALS
682.9 K
921.0
1.5%
PTCT
PTC Therapeutics Inc
682.3 K
9 033.0
1.5%
SNDX
Syndax Pharmaceuticals Inc
681.4 K
33.5 K
1.5%
CRNX
Crinetics Pharmaceuticals Inc
675.9 K
13.5 K
1.5%
ARWR
Arrowhead Pharmaceuticals Inc
675.9 K
9 749.0
1.5%
ROIV
Roivant Sciences Ltd
668.5 K
30.9 K
1.5%
UTHR
UNITED THERAPEUTICS CORP
648.8 K
1 382.0
1.4%
SRPT
SAREPTA THERAPEUTICS INC
645.6 K
31.7 K
1.4%
PHAT
Phathom Pharmaceuticals Inc
641.6 K
46.9 K
1.4%
TGTX
TG Therapeutics Inc
641.5 K
21.8 K
1.4%
1
2
3
4
新闻
First Quarter Earnings: Sharpening Sector Divergence
3 Reasons To Stick With Growth Stocks In Rotating Markets
Seeking Innovation Beyond Tech? Insight On Healthcare Stocks
Makary's Successor Faces Tough Task Managing FDA Amid Budget Cuts
What's The Dominant Trend In Earnings: AI Or Geopolitics?
Medical Technology Stocks: Innovation Endures As Valuations Reset
AI And The Future Of Healthcare
Global PMI: Tracking The Sectors Hit Hardest By The Middle East War
Can Forgotten Biotech Break Out?
Concerns Shift From Obsolescence To Oil
CDT Insider Sentiment March 2026: The Probability Race And Barbell Strategies
ImmunityBio Lead Bladder Cancer Drug Trial Clears Power Check - ImmunityBio (NASDAQ:IBRX)